XML 69 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1

Share Capital (Tables)

12 Months Ended

Dec. 31, 2024

Disclosure Of Share Capital, Reserves And Other Equity Interests [Abstract]

Schedule of Share Purchase Warrants Liability Classified

The following table summarizes the change in the number of issued and outstanding share purchase warrants and the associated warrant liabilities during the period ended December 31, 2024:

			Units			Amount
Listed Warrants – exercise price C$2.21, exercisable until Apr 30, 2024
As at December 31, 2022			10,064,255			$	9,667
Exercised			(763,103)			(924)
Fair value adjustment (Note 20)			—			6,329
Balance at December 31, 2023			9,301,152			$	15,072
Exercised			(8,546,249)			(15,200)
Fair value adjustment (Note 20)			—			128
Expired			(754,903)			—
Balance at December 31, 2024			—			$	—
Aris Unlisted Warrants(¹) – exercise price C$6.00, exercisable until Dec 19, 2024
Balance at December 31, 2022			1,650,000			588
Fair value adjustment (Note 20)			—			(35)
Balance at December 31, 2023			1,650,000			$	553
Exercised			(203,750)			(87)
Fair value adjustment (Note 20)			—			209
Expired			(1,446,250)			(675)
Balance at December 31, 2024			—			$	—
Aris Listed Warrants(¹) – exercise price C$5.50, exercisable until Jul 29, 2025
Balance at December 31, 2022			29,084,377			11,173
Exercised			(25,000)			(21)
Fair value adjustment (Note 20)			—			(171)
Balance at December 31, 2023			29,059,377			$	10,981
Exercised			(2,700)			(2)
Fair value adjustment (Note 20)			—			(2,093)
Balance at December 31, 2024			29,056,677			$	8,886
Total share purchase warrant liability at December 31, 2023						$	26,606
Total share purchase warrant liability at December 31, 2024						$	8,886

(1)Number of replacement warrants and exercise price have been adjusted by the share Exchange Ratio of 0.5.

Schedule of Equity Classified Warrants

The following table summarizes the change in the number of issued and outstanding equity classified share purchase warrants during the periods ending December 31, 2024 and December 31, 2023:

			Units			Common shares issuable
As at December 31, 2022			7,224,965			5,019,905
Exercised (1)			(281,500)			(195,586)
Expired			(2,795,090)			(1,942,029)
As at December 31, 2023			4,148,375			2,882,290
Exercised (2)			(3,915,079)			(2,771,550)
Expired			(233,296)			(110,740)
Balance at December 31, 2024			—			—

(1)The exercise price per Gold X Warrant exercised averaged C$2.14.

(2)The exercise price per Gold X warrant exercised averaged C$3.57.

Schedule of Change in Stock Options Outstanding

A summary of the change in the stock options outstanding during the periods ended December 31, 2024 and December 31, 2023 is as follows:

			Options outstanding			Weighted average exercise price (C$)
Balance at December 31, 2022			6,713,506			$	4.71
Options granted			1,778,931			3.99
Exercised (1)			(528,241)			3.27
Expired or cancelled			(683,076)			5.11
Balance at December 31, 2023			7,281,120			$	4.57
Options granted			2,875,700			4.22
Exercised (2)			(2,779,903)			4.03
Expired or cancelled			(821,318)			5.39
Balance at December 31, 2024			6,555,599			$	4.55

(1)The weighted average share price at the date stock options were exercised was C$4.10.

(2)The weighted average share price at the date stock options were exercised was C$5.47.

Schedule of Assumptions of Stock Options

A summary of the inputs used in the determination of the fair values of the stock options granted in the periods ended December 31, 2024 and December 31, 2023, using the Black-Scholes option pricing model, is as follows:

			12-Jan-2023						12-May-2023						2-Oct-2023						31-Jan-2024						1-Jul-2024						14-Nov-2024
Total options issued			1,691,964						26,815						60,152						2,525,561						343,443						6,696
Market price of shares at grant date			$4.03						$3.40						$3.09						$4.09						$5.17						$5.59
Exercise price			$4.03						$3.40						$3.09						$4.09						$5.17						$5.59
Dividends expected			Nil						Nil						Nil						Nil						Nil						Nil
Expected volatility			58.36					%	55.47					%	46.95					%	44.42					%	45.75					%	47.36					%
Risk-free interest rate			3.67					%	3.50					%	4.64					%	3.82%						3.83%						3.14					%
Expected life of options			3.0 years						3.0 years						3.0 years						3.0 years						3.0 years						3.0 years
Vesting terms			2 years			(1)			2 years			(1)			2 years			(1)			2 years			(1)			2 years			(1)			2 years			(1)

(1)50% of the options vest one year after issue date, the remaining 50% vest two years after issue date.

Schedule of Stock Options Outstanding

The table below summarizes information about the stock options outstanding and the common shares issuable as at December 31, 2024:

Expiry date			Outstanding			Vested stock options			Remaining contractual life in years			Exercise price (C$/share)
01-Mar-25			632,500			632,500			0.17			4.00
23-Mar-25			324,815			324,815			0.23			3.80
01-Apr-25			135,000			135,000			0.25			4.05
26-Jun-25			5,000			5,000			0.49			5.00
02-Jul-25			50,000			50,000			0.50			6.88
12-Jan-26			1,161,491			534,925			1.04			4.03
01-Apr-26			703,000			703,000			1.25			6.04
12-May-26			13,408			-			1.37			3.40
02-Oct-26			60,152			30,076			1.75			3.09
26-Jan-27			90,000			90,000			2.07			5.45
31-Jan-27			2,306,094			—			2.09			4.09
01-Apr-27			724,000			724,000			2.25			5.84
01-Jul-27			343,443			—			2.50			5.17
14-Nov-27			6,696			—			2.87			5.59
Balance at December 31, 2024			6,555,599			3,229,316			1.52			$	4.55

Schedule of DSU and PSU Liability

A summary of changes to the DSU liability, included in accounts payable and accrued liabilities, during the period ended December 31, 2024 and the year ended December 31, 2023 is as follows:

			Units			Amount
Balance at December 31, 2022			333,818			$	826
Granted and vested during the period			241,223			649
Change in fair value			—			428
Balance at December 31, 2023			575,041			$	1,903
Granted and vested during the period			167,571			631
Paid			(259,691)			(956)
Change in fair value			—			114
Balance at December 31, 2024			482,921			$	1,692

A summary of changes to the PSU liability during the period ended December 31, 2024 and the year ended December 31, 2023 is as follows:

			Units			Amount
Balance at December 31, 2022			706,286			$	292
Unvested PSUs recognized in the period			796,758			1,178
Vested PSUs recognized in the period			—			29
Paid			(30,325)			(47)
Change in fair value			—			1,352
Balance at December 31, 2023			1,472,719			$	2,804
Unvested PSUs recognized in the period			1,035,489			1,861
Expired/cancelled			(190,888)			—
Paid			(489,098)			(1,289)
Change in fair value			—			374
Balance at December 31, 2024			1,828,222			$	3,750
Less: current portion			—			(1,520)
Non-current portion as at December 31, 2024						$	2,230

Schedule of Share-based Compensation Expense

			Year-ended December 31,
			2024			2023
Stock-option expense			$	2,285		$	1,475
DSU expense			745			1,077
PSU expense			2,235			2,559
Total			$	5,265		$	5,111

Schedule of Earnings (Loss) per Share

			Year-ended December 31, 2024									Year-ended December 31, 2023
			Weighted average shares outstanding			Net earnings (loss) attributable to owners			Net earnings (loss) per share			Weighted average shares outstanding			Net earnings (loss) attributable to owners			Net earnings (loss) per share
Basic EPS			157,727,394			$	24,582		$	0.16		136,735,317			$	11,419		$	0.08
Effect of dilutive stock-options			487,022			—						5,717			—
Effect of dilutive warrants			476,863			(2,093)						321,471			—
Diluted EPS			158,691,279			$	22,489		$	0.14		137,062,505			$	11,419		$	0.08

Schedule of Items Excluded from EPS

The following table lists the number of warrants, stock options and Convertible Debenture which were excluded from the computation of diluted earnings per share. Instruments were excluded because either the instruments were not vested, the exercise prices exceeded the average market value of the common shares or the impact of including the in the money securities were anti-dilutive to EPS.

			Year-ended December 31,
			2024			2023
Stock options			1,477,000			6,893,305
Convertible Debenture			—			3,789,474
Warrants			—			43,224,654

X

- Definition

Description of Equity Classified Warrants

+ References

No definition available.

+ Details

Name:	aris_DescriptionOfEquityClassifiedWarrantsTableTextBlock
Namespace Prefix:	aris_
Data Type:	dtr-types1:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Description of Share Purchase Warrants Liability Classified

+ References

No definition available.

+ Details

Name:	aris_DescriptionOfSharePurchaseWarrantsLiabilityClassifiedTableTextBlock
Namespace Prefix:	aris_
Data Type:	dtr-types1:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure Of Share Capital, Reserves And Other Equity Interests

+ References

No definition available.

+ Details

Name:	aris_DisclosureOfShareCapitalReservesAndOtherEquityInterestsAbstract
Namespace Prefix:	aris_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 47
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future, but were not included in the calculation of diluted earnings per share because they are antidilutive for the period(s) presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2024-01-01
-Paragraph 70
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_70_c&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareExplanatory2023
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 45
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the range of exercise prices for outstanding share options.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 45
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of earnings per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2024-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2024-en-r&anchor=para_66&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_EarningsPerShareExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's profit (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 50
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_50&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration